Page results
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
-
The musculoskeletal (MSK) outpatient therapy service at University College Hospital provides assessment and treatment of patients for a variety of specialities including orthopaedic, rheumatology, hand therapy, women’s health, orthotic, podiatry and spinal non-operative and operative patients with musculoskeletal dysfunction.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
The sleep service at UCH is run within the department of Thoracic Medicine. We have particular expertise in the diagnosis and management of ventilatory disorders during sleep, including obstructive sleep apnoea syndrome, sleep disordered breathing and assessment of respiratory failure.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
Out-patient IV antibiotic service
-
This page explains what to do and what to avoid when your child has had extractions or minor oral surgery.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
File results
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services